Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP-103 in Moderate to Severe Acute Lower Back Pain
NCT05096494Phase 2Completed
- Sponsor
- Scilex Holding
- Start
- Apr 2022
- Primary completion
- May 2023
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SP-103 in low back pain (LBP), sponsored by Scilex Holding. Started Apr 2022; status: completed.
02
Drugs
SP-103
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT05096494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096494.